Found 18 matching trials
Multidisciplinary Design to Optimize Schizophrenia Treatment Based on Multi-omics Data and Systems Biology Analysis PHASE4 SchizOMICS is a Phase IV, multicenter, dose-flexible, open-label, randomize...
Show More Location
Multiple Locations
Learn More & Join Trial
Extension Study To Evaluate The Long-Term Safety, Tolerability, And Efficacy Of Low And High Doses Of Bl-1020 PHASE2 A Six-Week, Randomized, Double-Blind, Parallel Group Extension Study To Eva...
Show More Location
University of California, Irvine
Learn More & Join Trial
An Efficacy and Safety Study of Risperidone Long-Acting Microspheres in Participants With Schizophrenia, Schizophreniform or Schizoaffective Disorders PHASE4 The purpose of this study is to evaluate the efficacy and safety of long ac...
Show More Location
Multiple Locations
Learn More & Join Trial
High Dose Risperidone Consta for Patients With Schizophrenia With Poor Response to Risperidone PHASE4 The purpose of this study is to look at two doses of long-acting injectable...
Show More Location
Vanderbilt Psychiatric Hospital
Learn More & Join Trial
Insight Enhancement Program vs. Metacognitive Training for Psychosis in Patients With Schizophrenia: A Three-Armed Comparative Randomized Controlled Trial PHASE3 The aim of this study is to explore new safe effective psychotherapeutic in...
Show More Location
Agiad Psychiatry Hospital
Learn More & Join Trial
A Study to Assess the Clinical Utility of Antipsychotic Medication Levels in Plasma as Determined by Liquid Chromatography-Tandem Mass Spectrometry PHASE2 The purpose of this study is to determine the number of Medication Treatmen...
Show More Location
Multiple Locations
Learn More & Join Trial
Treatment of Acute Schizophrenia With Vitamin Therapy PHASE4 Controlled studies using the orthomolecular approach have been few (Deutsch...
Show More Location
Beersheva Mental Health Center
Learn More & Join Trial
Subjective Experience Following Psilocybin PHASE2 The purpose of this study is to determine the importance of the acute subje...
Show More Location
University of Calgary
Learn More & Join Trial
PK, Safety, and Tolerability Study of RBP-7000 of Different Molecular Weight Polymer in Subjects With Schizophrenia PHASE1 Primary Objective: To assess the relative bioavailability of RBP-7000 formu...
Show More Location
Collaborative Neuroscience Network, LLC
Learn More & Join Trial
Optimizing and Individualizing the Pharmacological Treatment of First-episode Schizophrenic Patients N/A The study is performed in 20 different hospitals from 19 cities in China. T...
Show More Location
Mental Health Institute of 2nd Xiangya Hospital,CSU
Learn More & Join Trial